Close
GS1 Global Healthcare Conference 2026
LiGHT 2026

Sorin Group acquired endoscopic vessel harvesting business from Datascope, Inc

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Related stories

WebMD Ignite Ruby Transforms Healthcare Marketing...

WebMD Ignite has announced the launch of WebMD Ignite...

Mayo Clinic Study Validates AI Tool...

Researchers at Mayo Clinic have found that an artificial...

MHRA Outlines New Agenda for AI...

The United Kingdomโ€™s Medicines and Healthcare products Regulatory Agency...

Sorin Group, a global company and a leader in the treatment of cardiovascular diseases, announced today that it has acquired the Clearglide(R) endoscopic vessel harvesting product line of Datascope Inc. Endoscopic vessel harvesting ("EVH") devices enable less-invasive harvesting of vessels for use in coronary artery bypass grafting. EVH procedures replace traditional open vessel harvesting, and avoid significant pain and discomfort for patients. In addition, the large incision that is required in an open vessel harvesting procedure is associated with a high rate of wound complications including dehiscence, hematoma and infection. The endoscopic approach is associated with fewer wound complications than the traditional open method.

Sorin Group, a global company and a leader in the treatment of cardiovascular diseases, announced today that it has acquired the Clearglide(R) endoscopic vessel harvesting product line of Datascope Inc. Endoscopic vessel harvesting ("EVH") devices enable less-invasive harvesting of vessels for use in coronary artery bypass grafting. EVH procedures replace traditional open vessel harvesting, and avoid significant pain and discomfort for patients. In addition, the large incision that is required in an open vessel harvesting procedure is associated with a high rate of wound complications including dehiscence, hematoma and infection. The endoscopic approach is associated with fewer wound complications than the traditional open method.

André-Michel Ballester, C.E.O. Sorin Group said, After conclusion in 2008 of our divestiture program, this transaction is a first step towards reinforcing our leading cardiac surgery franchises. This acquisition will be particularly exciting for Sorin Group's United States business as it will reinforce our product offering and consolidate our position as the leading provider of innovative solutions for the cardiac surgery clinical community.

Never miss a healthcare headline

Healthcare moves fast โ€“ stay on top of it with our must - read briefings.

  • The top hospital and healthcare stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments transforming global healthcare management

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media PackNow

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Latest stories

Related stories

Mayo Clinic Study Validates AI Tool DEXI for Skin Lesion Assessment

Researchers at Mayo Clinic have found that an artificial...

MHRA Outlines New Agenda for AI Medical Devices at AdvaMed

The United Kingdomโ€™s Medicines and Healthcare products Regulatory Agency...

UK Confirms Indefinite Use of CE Marked Medical Devices

The United Kingdom government has officially confirmed the indefinite...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป